Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6930119 | BRAINTREE | Liquid pharmaceutical composition |
Jul, 2022
(2 years ago) |
Drugs and Companies using NIZATIDINE ingredient
Market Authorisation Date: 25 May, 2004
Treatment: NA
Dosage: SOLUTION
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7291324 | BRAINTREE | Method of bowel cleansing |
Oct, 2022
(1 year, 9 months ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Product(NP) | Jul 16, 2013 |
Market Authorisation Date: 16 July, 2010
Treatment: Gastrointestinal lavage indicated for cleansing of the colon as a preparation for colonoscopy in adults
Dosage: FOR SOLUTION, TABLET, DELAYED RELEASE; TABLET, DELAYED RELEASE, FOR SOLUTION